Businesses Are United Against the Attack on Drug Innovation

The idea that American business is divided over the bill is pure partisan propaganda. Opposition to the bill in total is unanimous. 

…From the Small Business and Entrepreneurship Council to the U.S. Chamber of Commerce, businesses large and small are vociferously opposed to Democrats' plan to impose arbitrary price caps on prescription medicines.  

…These unprecedented price controls would be the foot in the door to government run health care. The so-called Public Option to provide universal health care relies on price controls for doctors and hospitals. Getting drugs under this structure is the first step to establishing a nationwide government health program that would significantly reduce access. 

Companies are also rightfully worried about the harmful precedent the legislation sets. If the government can dictate prices to the pharmaceutical industry, what other sectors could it upend on a whim?

Finally, every independent expert estimates the bill will reduce new treatments and cures for diseases like cancer, diabetes and heart disease. This means worse health for employees, more disease progression, and higher long-term costs. 

Corporate America as a whole is entirely right to worry about price controls.